Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

HLA class I/II binding tumour associated peptides (ADF-APO-CCN-GUC-K67-MET- MMP-MUC-RGS)

EU orphan designation number: EU/3/07/433   
Active ingredient: HLA class I/II binding tumour associated peptides (ADF-APO-CCN-GUC-K67-MET- MMP-MUC-RGS)
Indication: Treatment of renal cell carcinoma
Sponsor: Immatics Biotechnologies GmbH
Paul-Ehrlich-Str. 15, D-72076 Tuebingen, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/02/2007 Orphan Designation EMEA/OD/059/06 (2007)538 of 15/02/2007